Drug Shortage Report for IDARUBICIN
Report ID | 201980 |
Drug Identification Number | 02410028 |
Brand name | IDARUBICIN |
Common or Proper name | IDARUBICIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | IDARUBICIN HYDROCHLORIDE |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1X5ML |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-07 |
Estimated end date | |
Actual end date | 2023-12-18 |
Shortage status | Resolved |
Updated date | 2023-12-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-08-16 | English | Compare |
v2 | 2023-08-16 | French | Compare |
v3 | 2023-10-17 | English | Compare |
v4 | 2023-11-07 | English | Compare |
v5 | 2023-11-07 | English | Compare |
v6 | 2023-11-07 | French | Compare |
v7 | 2023-11-08 | English | Compare |
v8 | 2023-12-18 | English | Compare |
v9 | 2023-12-18 | French | Compare |
v10 | 2023-12-19 | English | Compare |
Showing 1 to 10 of 10